InvestorsHub Logo
Followers 15
Posts 240
Boards Moderated 0
Alias Born 01/31/2018

Re: Scooter McCabe post# 71915

Tuesday, 04/28/2020 5:04:33 PM

Tuesday, April 28, 2020 5:04:33 PM

Post# of 232949
I don't think it is unusual to have different prices in different indications. Costs don't just include development and manufacturing. It's also appropriate that the (highly variable) costs of the relevant clinical trials should be amortized over the (highly variable) market size for relevant indication.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News